Quick Answer
OS Therapies Inc reported Net Income of -$28.75 million for fiscal year 2025.
OS Therapies Inc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$28.75M | -223.7% |
| 2024 | -$8.88M | -14.0% |
| 2023 | -$7.79M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.88M | -139.3% | -51.6% |
| June 30, 2025 | -$4.54M | -191.3% | -17.0% |
| March 31, 2025 | -$3.88M | -165.7% | -34.8% |
| September 30, 2024 | -$2.88M | -45.6% | -84.6% |
| June 30, 2024 | -$1.56M | +37.8% | -6.8% |
| March 31, 2024 | -$1.46M | +21.0% | +26.1% |
| September 30, 2023 | -$1.97M | — | +21.2% |
| June 30, 2023 | -$2.51M | — | -35.6% |
- OS Therapies Inc showed a decrease of -223.7% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, OS Therapies Inc’s net income has declined by 269.0% (from -$7.79 million to -$28.75 million).
- The most recent figure is from OS Therapies Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: